197 related articles for article (PubMed ID: 37095586)
21.
Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
[TBL] [Abstract][Full Text] [Related]
22. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study.
Ou J; Wu L; Li R; Wu CQ; Liu J; Chen TW; Zhang XM; Tang S; Wu YP; Yang LQ; Tan BG; Lu FL
Quant Imaging Med Surg; 2021 Feb; 11(2):628-640. PubMed ID: 33532263
[TBL] [Abstract][Full Text] [Related]
23. A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072).
Liu W; Zeng C; Wang S; Zhan Y; Huang R; Luo T; Peng G; Wu Y; Qiu Z; Li D; Wu F; Chen C
Front Oncol; 2022; 12():1026305. PubMed ID: 37078004
[TBL] [Abstract][Full Text] [Related]
24. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
[TBL] [Abstract][Full Text] [Related]
25. A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy.
Du F; Tang N; Cui Y; Wang W; Zhang Y; Li Z; Li J
Front Oncol; 2020; 10():596013. PubMed ID: 33392091
[TBL] [Abstract][Full Text] [Related]
26. Value of computed tomography radiomics combined with inflammation indices in predicting the efficacy of immunotherapy in patients with locally advanced and metastatic non-small cell lung cancer.
Shao H; Zhu J; Shi L; Yao J; Wang Y; Ma C; Swierniak A; Ni B
J Thorac Dis; 2024 May; 16(5):3213-3227. PubMed ID: 38883654
[TBL] [Abstract][Full Text] [Related]
27. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
28. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
Front Nutr; 2022; 9():896847. PubMed ID: 35990358
[TBL] [Abstract][Full Text] [Related]
29. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract][Full Text] [Related]
30. Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
Yang M; Shi L; Huang T; Li G; Shao H; Shen Y; Zhu J; Ni B
J Thorac Dis; 2023 Feb; 15(2):635-648. PubMed ID: 36910079
[TBL] [Abstract][Full Text] [Related]
31. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a radiomics-based nomogram for the prediction of postoperative malnutrition in stage IB1-IIA2 cervical carcinoma.
Yu W; Xu H; Chen F; Shou H; Chen Y; Jia Y; Zhang H; Ding J; Xiong H; Wang Y; Song T
Front Nutr; 2023; 10():1113588. PubMed ID: 36819703
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
35. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Yang Z; He B; Zhuang X; Gao X; Wang D; Li M; Lin Z; Luo R
J Radiat Res; 2019 Jul; 60(4):538-545. PubMed ID: 31111948
[TBL] [Abstract][Full Text] [Related]
36. The value of
Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
[TBL] [Abstract][Full Text] [Related]
37. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
[TBL] [Abstract][Full Text] [Related]
38. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
Li L; Sun J; Liu N; Yu R; Zhang J; Pang J; Ou Q; Yin Y; Cui J; Yao X; Zhao R; Shao Y; Yuan S; Yu J
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):382-394. PubMed ID: 36167753
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma.
Cao B; Mi K; Dai W; Liu T; Xie T; Li Q; Lang J; Han Y; Peng L; Wang Q
Chin J Cancer Res; 2022 Apr; 34(2):71-82. PubMed ID: 35685995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
